FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/21/2023
Back to search
Official data from USPTO
SCIRENT CLINICAL RESEARCH AND SCIENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
03/21/2023
Trademark type
Combined
Nice classes
42
Filing date
04/21/2021
Registration date
10/11/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/11/2022
Last transaction
10/11/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
RS
Examiner
BLANE, SUZANNE
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The sign consists of the word SCIRENT, in Latin capital letters, in black. Below the word SCIRENT, there are four words - Clinical Research and Science, in Latin letters, in blue. In the upper right corner, above the word SCIRENT there is a circle in different shades of green and blue (light green, dark green, light blue, dark blue) whose center is painted in white
Holders and representatives
Holders
SCIRENT CLINICAL RESEARCH AND SCIENCE D.O.O. BEOGRAD-VRACAR
Representatives
Clemens W. Pauly Pauly P.A.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical and scientific research and data analysis services; implementation and analysis of clinical trials in the field of medicinesmedical devicesbiotechnology and natural sciences; development of protocolsscientific consultationpreparation of reports with respect to medical research; research center project management; local and global clinical trial project management; pharmaceutical drug development servicesdevelopment of clinical trial methodologies; consultancy services in the field of pharmaceutical clinical trials; extensive clinical research services for others; electronic storage services for clinical trial data; biostatic analysis; services provided by consultants with respect to research in the field of environmental protectionpreclinical research and evaluation of pharmaceutical product development; conducting clinical trials for others in the nature of scientific researchespecially the correction of clinical trials and defective records; clinical trial services in the nature of strategic management of clinical research portfolios and follow-up of biological monitoring; providing information in the field of natural sciences and scientific research to physicians and other health professionalsto patients and to medicalpharmaceutical and biotechnological companies; providing technical drafting services for complaints and/or disputes in the field of medical research and clinical studies; consultation services in the field of clinical research under contract and product development under contact; design and development of computer hardware as well as consultation services relating thereto for others; creating websites featuring blogs on medical and pharmaceutical information relating to chronic conditions and diseases; creating and maintaining Internet websites for patients and registered care providers to form virtual communities and to engage in the field of health; design and development of an interactive software for use in the communication and dissemination of medical and pharmaceutical information
Publications
History of USPTO decisions and trademark events.
25 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
01/30/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
01/30/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/11/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/11/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/11/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/26/2022
PUBO
PUBLISHED FOR OPPOSITION
07/26/2022
GPNX
NOTIFICATION PROCESSED BY IB
07/25/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/07/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/06/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/06/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/22/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/04/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/04/2022
RFNT
REFUSAL PROCESSED BY IB
02/06/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/18/2022
RFRR
REFUSAL PROCESSED BY MPU
01/18/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/23/2021
CNRT
NON-FINAL ACTION WRITTEN
12/22/2021
DOCK
ASSIGNED TO EXAMINER
12/15/2021
MAFR
APPLICATION FILING RECEIPT MAILED
10/01/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/27/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/16/2021
Continuous trademark protection
Get notified about every new filing that threatens SCIRENT CLINICAL RESEARCH AND SCIENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.